Skip to main content
Premium Trial:

Request an Annual Quote

New Products Posted to GenomeWeb: Philip Morris International, MGI, PreOmics

Philip Morris International GladiaTox

Philip Morris International (PMI) has launched GladiaTox, an open-source informatics product for high-content screening data in biomedical research. According to PMI, GladiaTox allows "robust and efficient storage, processing, and reporting of HCS data, in line with the landmark 21st Century Toxicology program." The firm's platform is an evolution of the ToxCast Pipeline created for the US Environmental Protection Agency. The solution can analyze disparate types of HCS data in an integrated fashion and supports the "3S" approach to biological understanding – "systematic, systemic, and systems," which looks at organisms in their entirety rather than specific organs in isolation. PMI developed GladiaTox in collaboration with Filer Consulting.


MGI Single-Cell RNA Sequencing Solution

BGI subsidiary MGI has begun marketing a product solution that allows users of BGI and MGI sequencing platforms to perform single-cell RNA sequencing (scRNA-seq) with 10x Genomics' technology. The solution includes the MGIEasy Universal Library Conversion Kit, a new product, as well as the 10x Genomics Chromium Controller and Single-Cell RNA Solutions. Researchers from the UK and Australia recently tested BGI's sequencing technology for scRNA-seq with 10x Genomics' platform.


PreOmics PreON

PreOmics has launched its PreON protein sample preparation platform. According to the company's website, PreON processes 4 to 12 samples in less than three hours and uses a plug-and-play method selection that streamlines protein sample processing for mass spectrometry-based protein analysis. The benchtop system also features an onboard heated shaker, automated swing-out centrifuge, and automated pipetting, and is designed to eliminate both manual processing steps and errors.


For more new products and services, please visit the New Products page on our website.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.